Enhancing immune checkpoint blockade therapy of genitourinary malignancies by co-targeting PMN-MDSCs is a research paper published in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022). On theSindex it has a DataRank of 0. It has been cited 14 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Susan G. Komen
Grant: CCR18548293
National Institutes of Health
Grant: R01CA248033
Department of Defense Prostate Cancer Research Program
Grant: W81XWH2010312
Department of Defense Prostate Cancer Research Program
Grant: W81XWH2010332
Mary Kay Foundation
Grant: 07-19
NIGMS NIH HHS
Grant: P20 GM121176
NCI NIH HHS
Grant: R01 CA280097
European Commission
Grant: 248033
Molecular Basis for Unwanted Side-Effects During Interferon Therapy
National Institutes of Health
Grant: 5R01CA248033-04
Converting Cold to Hot Tumor Microenvironment in Prostate Cancer by Targeting Chromatin Effector
American Institute for Cancer Research
U.S. Department of Defense
Elsa U. Pardee Foundation
FWCI
0.90
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals